SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tyche Industries gets US FDA approval for its manufacturing facility in Andhra Pradesh

12 May 2016 Evaluate

Tyche Industries has received US Food and Drug Administration (US FDA) approval for its active pharmaceutical ingredients (API) manufacturing facility located in Kakinada, Andhra Pradesh.

The company manufactures and exports APIs, intermediates and nutraceuticals. The company posted a profit of Rs 23 lakh on a topline of Rs 14.16 crore for the quarter ended December 2015.

Tyche Inds Share Price

134.80 9.35 (7.45%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×